180 Participants Needed

Priming Intervention for Psoriasis

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Wake Forest University Health Sciences
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Biologic medications have revolutionized the treatment of inflammatory diseases such as moderate-to-severe psoriasis. Though very effective with an excellent safety profile, patients may be apprehensive about choosing a biologic medication for a variety of reasons. The purpose of this research study is to learn more about patient's perception of certain psoriasis treatment options.

Who Is on the Research Team?

SR

Steven R Feldman

Principal Investigator

Wake Forest University

Are You a Good Fit for This Trial?

This trial is for English-speaking individuals with psoriasis or their caregivers. It's not open to those who have already tried and did not respond well to specific biologic drugs like ustekinumab, guselkumab, risankizumab, or tildrakizumab.

Inclusion Criteria

Subjects with a working knowledge of English.
I have psoriasis or I am caring for someone with psoriasis.

Exclusion Criteria

I have tried or am currently on an IL-23 inhibitor like ustekinumab without success.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Survey Administration

Participants are randomized into three groups and administered surveys querying willingness to use a biologic medication

1 week
1 visit (virtual)

Follow-up

Participants are monitored for survey responses and willingness to use biologic medication

12 months

What Are the Treatments Tested in This Trial?

Interventions

  • Group #2 (Intervention)
  • Group #3 (Intervention)
Trial Overview The study aims to understand how people with psoriasis feel about injectable biologic medications as a treatment option. Participants will be divided into groups receiving different educational interventions regarding these treatments.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Group #3 (Intervention)Experimental Treatment1 Intervention
Group II: Group #2 (Intervention)Experimental Treatment1 Intervention
Group III: Group #1 (Control)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Wake Forest University Health Sciences

Lead Sponsor

Trials
1,432
Recruited
2,506,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security